{"entity":{"type":"insider","cik":"0001666790","url":"/insider/0001666790","json_url":"/insider/0001666790.json","name":"Bonner Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2016-11-18","last":"2018-08-31","span_basis":"filed_date"},"name_variants":[{"name":"Bonner Michael","source":"filing","n_filings":8,"first_seen":"2016-11-18","last_seen":"2018-08-31"}],"transactions":[{"id":6267336,"accession":"0001209191-18-049112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-049112","line_url":"/filing/0001209191-18-049112#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":6.24,"price_display":"6.24","price_state":"stated","total_value":624.0,"total_display":"624.00","total_whole":"624","shares_owned_after":18454.0,"shares_owned_after_display":"18,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-29","filed_date":"2018-08-31","scope":"insider"},{"id":6267333,"accession":"0001209191-18-049112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-049112","line_url":"/filing/0001209191-18-049112#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":1776.0,"total_display":"1,776.00","total_whole":"1,776","shares_owned_after":18354.0,"shares_owned_after_display":"18,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-31","scope":"insider"},{"id":6016766,"accession":"0001209191-18-031475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031475","line_url":"/filing/0001209191-18-031475#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":6.12,"price_display":"6.12","price_state":"stated","total_value":2448.0,"total_display":"2,448.00","total_whole":"2,448","shares_owned_after":18054.0,"shares_owned_after_display":"18,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-18","scope":"insider"},{"id":6133234,"accession":"0001209191-18-021463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021463","line_url":"/filing/0001209191-18-021463#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":6.72,"price_display":"6.72","price_state":"stated","total_value":2016.0,"total_display":"2,016.00","total_whole":"2,016","shares_owned_after":15997.0,"shares_owned_after_display":"15,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-23","scope":"insider"},{"id":4326251,"accession":"0001209191-17-062464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-062464","line_url":"/filing/0001209191-17-062464#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":1952.5,"total_display":"1,952.50","total_whole":"1,953","shares_owned_after":15697.0,"shares_owned_after_display":"15,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-24","scope":"insider"},{"id":4784822,"accession":"0001209191-17-050310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-050310","line_url":"/filing/0001209191-17-050310#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":6.72,"price_display":"6.72","price_state":"stated","total_value":3360.0,"total_display":"3,360.00","total_whole":"3,360","shares_owned_after":15447.0,"shares_owned_after_display":"15,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-23","filed_date":"2017-08-25","scope":"insider"},{"id":4905329,"accession":"0001209191-17-037364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-037364","line_url":"/filing/0001209191-17-037364#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":2085.0,"total_display":"2,085.00","total_whole":"2,085","shares_owned_after":14947.0,"shares_owned_after_display":"14,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-31","filed_date":"2017-06-02","scope":"insider"},{"id":4160446,"accession":"0001209191-17-022787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-022787","line_url":"/filing/0001209191-17-022787#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":6.42,"price_display":"6.42","price_state":"stated","total_value":5778.0,"total_display":"5,778.00","total_whole":"5,778","shares_owned_after":12800.0,"shares_owned_after_display":"12,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-03-24","scope":"insider"},{"id":3087058,"accession":"0001209191-16-151281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151281","line_url":"/filing/0001209191-16-151281#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001666790","owner_name":"Bonner Michael","owner_display_name":"Bonner Michael","owner_url":"/insider/0001666790","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":4950.0,"total_display":"4,950.00","total_whole":"4,950","shares_owned_after":11900.0,"shares_owned_after_display":"11,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001087294","name":"CUMBERLAND PHARMACEUTICALS INC","url":"/issuer/0001087294","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2016-11-18","last_seen":"2018-08-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001666790","retrieved_at":"2026-08-24T15:54:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}